Jane Street »

Apimeds Pharmaceuticals Us I shares owned by Jane Street

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $45k 27k 1.64

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Jane Street
UBS Group
Tower Research Capital

View all funds holding Apimeds Pharmaceuticals Us I